NCT04407130View on ClinicalTrials.gov

Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection.

PHASE2CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

June 16, 2020

Primary Completion Date

October 30, 2020

Study Completion Date

November 20, 2020

Conditions
COVID-19 Patients
Interventions
DRUG

Ivermectin + Doxycycline + Placebo

"Arm I: 200 mcg/kg (12 mg tablet) ivermectin (IVERA) single dose and 200 mg stat doxycycline day-1 followed by 100mg doxycycline 12hrly for 4 day (i.e. day2-day5)~Placebo one tablet D2-5"

DRUG

Ivermectin + Placebo

Arm II: Ivermectin - 200 mcg/kg (12 mg tablet) once per day D1-D5 + Placebo two tablets D1 followed by Placebo one tablet D2-5

DRUG

Placebo

Arm III: 3 Placebo tablets D1 followed by 2 tablets D2-5

Trial Locations (1)

1000

Icddr,B, Dhaka

All Listed Sponsors
lead

International Centre for Diarrhoeal Disease Research, Bangladesh

OTHER

NCT04407130 - Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. | Biotech Hunter | Biotech Hunter